Explore more publications!
France Daily Times
Got News to Share?

France Daily Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on France Daily Times.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on February 10, 2026

PPWR Copilot launches to simplify EU packaging labelling and documentation for exporters
Feb. 10, 2026

PPWR Copilot launches to simplify EU packaging labelling and documentation for exporters

Indeterminate EIN Presswire
Eccentex Announces Applied AI Orchestration Capabilities to Power Human-Centered Case Work Automation
Feb. 10, 2026

Eccentex Announces Applied AI Orchestration Capabilities to Power Human-Centered Case Work Automation

Indeterminate EIN Presswire
Keis To Joi Debuts at Bergan American Furs & Fashion
Feb. 10, 2026

Keis To Joi Debuts at Bergan American Furs & Fashion

Indeterminate EIN Presswire
SNUFFIES Eliminates Guesswork From Collectibles Buying With Community-Driven Platform
Feb. 10, 2026

SNUFFIES Eliminates Guesswork From Collectibles Buying With Community-Driven Platform

Indeterminate EIN Presswire
Décryptage 2026 : Doyield montre aux hôteliers comment tripler leur taux de conversion face aux OTA
Feb. 10, 2026

Décryptage 2026 : Doyield montre aux hôteliers comment tripler leur taux de conversion face aux OTA

Indeterminate EIN Presswire
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
Feb. 10, 2026

DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting

Indeterminate GlobeNewswire
Nayla Grace, An AI Persona, Launched 2 Singles With A Third Single Coming On February 13, 2026
Feb. 10, 2026

Nayla Grace, An AI Persona, Launched 2 Singles With A Third Single Coming On February 13, 2026

Indeterminate EIN Presswire
Global Key Solutions Launches KeyPedia™, AI-Powered Regulatory Intelligence Platform for Pharma Compliance
Feb. 10, 2026

Global Key Solutions Launches KeyPedia™, AI-Powered Regulatory Intelligence Platform for Pharma Compliance

Indeterminate EIN Presswire
Muutokset Nokia Oyj:n omien osakkeiden omistuksessa
Feb. 10, 2026

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Indeterminate GlobeNewswire
Changes in Nokia Corporation's own shares
Feb. 10, 2026

Changes in Nokia Corporation's own shares

Indeterminate GlobeNewswire
Communiqué de presse : Sanofi finalise l’acquisition de Dynavax
Feb. 10, 2026

Communiqué de presse : Sanofi finalise l’acquisition de Dynavax

Indeterminate GlobeNewswire
Press Release: Sanofi completes the acquisition of Dynavax
Feb. 10, 2026

Press Release: Sanofi completes the acquisition of Dynavax

Indeterminate GlobeNewswire
EAGLES and newcleo join forces on LEANDREA
Feb. 10, 2026

EAGLES and newcleo join forces on LEANDREA

Indeterminate GlobeNewswire
STMicroelectronics introduces the first automotive microcontroller with AI acceleration for edge intelligence
Feb. 10, 2026

STMicroelectronics introduces the first automotive microcontroller with AI acceleration for edge intelligence

Indeterminate GlobeNewswire
Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026
Feb. 10, 2026

Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026

Indeterminate GlobeNewswire
Nicox : Présentation des données des études de Phase 3 de NCX 470 au congrès annuel 2026 de l’American Glaucoma Society (AGS)
Feb. 10, 2026

Nicox : Présentation des données des études de Phase 3 de NCX 470 au congrès annuel 2026 de l’American Glaucoma Society (AGS)

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions